Our insight was simple: ultrasound can do much more than anyone realized. By using energy to stimulate tissue in concert with ultrasound, we can see whole new dimensions.
The photo-acoustic ultrasound technology we first created for laboratory research of complex diseases—Nexus 128—led us to an even more powerful enhancement for clinical use: Thermo-Acoustic Enhanced UltraSound (TAEUS®).
TAEUS® enables clinicians to see tissue in ways previously possible only with CT or MRI—at a fraction of the cost, and at the point of care.Explore TAEUS® >
Non-Alcoholic Fatty Liver Disease (NAFLD) is difficult to identify and monitor. ENDRA is enhancing ultrasound to change that.Explore liver applications >
We are a passionate group of engineers, healthcare professionals and commercial leaders with decades of experience in solving complex technical problems. We’re working to uncover cost-effective solutions to some of the world’s most difficult healthcare challenges.
Learn how ENDRA is using ultrasound to help make difficult-to-diagnose diseases easier to find and treat.Watch the video >
Thermo-Acoustic Enhanced UltraSound will revolutionize what doctors can see and do at the patient bedside.Watch the video >
Our partnerships with leading medical researchers, engineers and manufacturers support ENDRA’s commitment to bringing TAEUS® to market. We benefit from each of these companies’ deep expertise.
“We believe that ENDRA’s technology has the potential to bring significant new capabilities to ultrasound—which aligns well with GE Healthcare’s mission of increasing access to high-quality, cost-effective healthcare”
ENDRA operates a Quality Management System which complies with the requirements of ISO 13485:2016 & EN ISO 13485:2016 for the following scope:
Certificate number: MD 697226
Effective Date: 2019-04-02
Expiry Date: 2022-04-01